COVID-19 (severe/critical) |
Treatment |
Concomitant medication [Treated with glycosidase inhibitors vs. Not received] |
Odds ratio: 1.950 (0.550-6.920)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Treatment |
Concomitant medication [Treated with diuretics vs. Not received] |
Odds ratio: 0.610 (0.180-2.050)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Treatment |
Concomitant medication [Treated with calcium channel blocker vs. Not received] |
Odds ratio: 0.520 (0.240-1.130)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Treatment |
Concomitant medication [Treated with ARBs vs. Not received] |
Odds ratio: 0.770 (0.360-1.630)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Treatment |
Concomitant medication [Treated with ACEi vs. Not received] |
Odds ratio: 1.230 (0.190-7.930)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Treatment |
Concomitant medication [Treated with Glucocorticoids vs. Not received] |
Odds ratio: 7.560 (1.170-48.930)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cancer [Present vs. Not present] |
Odds ratio: 1.940 (0.500-7.520)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cardiovascular or cerebrovascular disease [Present vs. Not present] |
Odds ratio: 0.940 (0.310-2.830)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.350 (1.470-3.760)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 1.200 (0.640-2.240)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 1.080 (0.560-2.080)
§ |
Yan
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Chronic liver disease [Present vs. Not present] |
Odds ratio: 0.830 (0.320-2.180)
§ |
Yan
|
|
|
COVID-19 (death) |
Laboratory Findings |
LDL [Lowered vs. Normal] |
Odds ratio: 21.720 (1.400-337.540)
|
Fan
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
LDL [Lowered vs. Normal] |
Odds ratio: 4.480 (1.550-12.920)
|
Fan
|
|
|
COVID-19 (death) |
Complications |
Cardiac injury [Present vs. Not present] |
Risk ratio: 3.850 (2.130-6.960)
|
Li
|
|
|
COVID-19 (severe/fatal) |
Laboratory Findings |
CRP [Abnormal vs. Normal] |
Odds ratio: 96.500 (4.600-2017.600)
§ |
Zhang
|
|
|
COVID-19 (severe/fatal) |
Complications |
Lymphopenia [Present vs. Not present] |
Odds ratio: 17.300 (1.100-261.800)
§ |
Zhang
|
|
|
COVID-19 (severe/fatal) |
Comorbidities |
Any comorbidity [Present vs. Not present] |
Odds ratio: 52.600 (3.600-776.400)
§ |
Zhang
|
|
|
COVID-19 (severe/fatal) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 24.800 (1.800-342.100)
§ |
Zhang
|
|
|
COVID-19 (death) |
Laboratory Findings |
hs-CRP [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.010 (1.000-1.020)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
eGFR [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.040 (0.920-1.160)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
Creatinine [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.040 (0.960-1.130)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
AST [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.040 (0.990-1.090)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
ALT [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 0.980 (0.940-1.020)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
D-dimer [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.070 (0.950-1.220)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
Hs-TnI [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.030 (1.000-1.070)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
Procalcitonin [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 0.960 (0.730-1.270)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.000 (0.999-1.001)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
Serum N-terminal pro B-type natriuretic peptide (NT-proBNP) [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.000 (0.999-1.001)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
Lymphocyte count [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 0.010 (0.001-0.140)
§ |
Sun
|
|
|
COVID-19 (death) |
Laboratory Findings |
WBC [1 unit increase (at admission) vs. Not applicable] |
Odds ratio: 1.280 (1.000-1.640)
§ |
Sun
|
|
|
COVID-19 (death) |
Comorbidities |
Chronic respiratory disease [Present vs. Not present] |
Odds ratio: 3.240 (0.450-23.570)
§ |
Sun
|
|
|
COVID-19 (death) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 0.820 (0.240-2.750)
§ |
Sun
|
|
|
COVID-19 (death) |
Symptoms |
Consciousness disorders [Present vs. Not present] |
Odds ratio: 1.380 (0.080-24.000)
§ |
Sun
|
|
|
COVID-19 (death) |
Vital Signs |
Respiratory rate [1 unit increase vs. Not applicable] |
Odds ratio: 1.130 (0.940-1.350)
§ |
Sun
|
|
|
COVID-19 (death) |
Vital Signs |
Heart rate [1 unit increase vs. Not applicable] |
Odds ratio: 1.000 (0.960-1.040)
§ |
Sun
|
|
|
COVID-19 (death) |
Vital Signs |
Oxygen saturation [1 unit increase vs. Not applicable] |
Odds ratio: 0.970 (0.860-1.090)
§ |
Sun
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Female vs. Male] |
Odds ratio: 0.320 (0.040-2.410)
§ |
Sun
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.120 (1.010-1.250)
§ |
Sun
|
|
|
COVID-19 (any condition) |
Symptoms |
Sore throat [Present vs. Not present] |
Odds ratio: 0.230 (0.110-0.500)
§ |
Yan
|
|
|
COVID-19 (any condition) |
Symptoms |
Nausea [Present vs. Not present] |
Odds ratio: 2.710 (1.070-6.830)
§ |
Yan
|
|
|
COVID-19 (any condition) |
Symptoms |
Fever [Present vs. Not present] |
Odds ratio: 1.670 (0.770-3.600)
§ |
Yan
|
|
|
COVID-19 (any condition) |
Symptoms |
Fatigue [Present vs. Not present] |
Odds ratio: 1.230 (0.500-3.040)
§ |
Yan
|
|
|
COVID-19 (any condition) |
Symptoms |
Myalgia/Arthralgia [Present vs. Not present] |
Odds ratio: 1.530 (0.710-3.330)
§ |
Yan
|
|
|
COVID-19 (any condition) |
Symptoms |
Anosmia [Present vs. Not present] |
Odds ratio: 10.920 (5.080-23.530)
§ |
Yan
|
|
|
COVID-19 (any condition) |
Symptoms |
Ageusia [Present vs. Not present] |
Odds ratio: 10.230 (4.740-22.090)
§ |
Yan
|
|
|
COVID-19 (any condition) |
Treatment |
Treatment history [Treated with beta-blockers vs. Not present] |
Odds ratio: 0.990 (0.910-1.080)
§ |
Mancia
|
|
|
COVID-19 (any condition) |
Treatment |
Treatment history [Treated with diuretics vs. Not present] |
Odds ratio: 1.060 (0.960-1.170)
§ |
Mancia
|
|
|
COVID-19 (any condition) |
Treatment |
Treatment history [Treated with calcium channel blocker vs. Not received] |
Odds ratio: 1.030 (0.950-1.120)
§ |
Mancia
|
|
|
COVID-19 (any condition) |
Treatment |
Treatment history [Treated with ARBs vs. Not received] |
Odds ratio: 0.950 (0.870-1.070)
§ |
Mancia
|
|
|